Green Car Congress  
Go to GCC Discussions forum About GCC Contact  RSS Subscribe Twitter headlines

« Hong Kong teams engineers camelina for faster growth and higher seed yield | Main | UK launches new $1.6B commercialization program for Carbon Capture and Storage (CCS) and first UK CCS Roadmap; making a play for global leadership »

Print this post

Solazyme and Bunge form joint venture for commercial-scale renewable oil production facility in Brazil

3 April 2012

Solazyme
Solazyme produces tailored oils using heterotrophic algae grown in industrial fermenters. Source: Solazyme. Click to enlarge.

Algae-based renewable oil company Solazyme, Inc. and Bunge Global Innovation LLC, a wholly-owned subsidiary of agribusiness and food company Bunge Limited, along with other Bunge subsidiaries have signed definitive agreements forming a joint venture to build, own and operate a commercial-scale renewable tailored oils production facility adjacent to Bunge’s Moema sugarcane mill in Brazil. (Earlier post.)

The JV, which will operate under the name Solazyme Bunge Produtos Renováveis Ltda., will have an expected annual production capacity of 100,000 metric tons of oil. The facility will utilize Solazyme’s renewable tailored oil production technology, coupled with Bunge’s sugarcane supply and processing capabilities, to produce sustainable tailored triglyceride oils for use in oleochemical and fuel applications in the Brazilian domestic market. Financial terms of the agreements were not disclosed.

Solazyme uses heterotrophic microalgae—i.e., they grow in the dark (in fermenters) by consuming sugars derived from plants that have already harnessed the sun’s energy. Using standard industrial fermentation equipment, Solazyme can scale and accelerate microalgae’s natural oil production time to just a few days and at commercial levels.

Further, Solazyme can design and produce novel tailored oils that cannot be achieved through blending of existing oils alone. The company optimizes microalgae to produce oil profiles with different carbon chain lengths, saturation levels and functional groups to modify important oil characteristics.

As an example in the fuels sector, Solazyme tailors its oil to meet refiner requirements and can be optimize it for refining processes. Refining of Solazyme oils tailored to make diesel fuel yields a substantially higher percentage of finished diesel by volume (more than 85%) than conventional petroleum, according to the company.

The tailored oils we expect to produce will not only expand our portfolio and address the growing demand of the fuels and oleochemicals industries, but also increase our capabilities to leverage new technologies for future opportunities in sugar and bioenergy.

—Ben Pearcy, Managing Director, Sugar & Bioenergy, and Chief Development Officer, Bunge Limited

The facility, which will be equally financed by Solazyme and Bunge, has been designed to integrate with a new cogeneration unit at the Moema mill, and can be expanded for further production in line with market demand. Startup is expected in the second half of 2013.

The announcement of the new JV follows a history of collaboration between the two companies, beginning with Bunge’s 2010 equity investment in Solazyme, followed by a May 2011 Bunge-funded Joint Development Agreement (JDA) to develop oils that could be sold commercially.

Also in May 2011, Solazyme granted warrants to Bunge for the purchase of Solazyme shares, conditional on key milestones related to the timely implementation of the JV and plant construction. In August 2011, Solazyme and Bunge announced that they had entered into a Joint Venture Framework Agreement setting forth the preliminary terms of the JV and commencing engineering for the plant. This series of agreements has now culminated in the formation of the JV.

April 3, 2012 in Algae, Algal Fuels, Bio-hydrocarbons, Biodiesel, Fuels | Permalink | Comments (3) | TrackBack (0)

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341c4fbe53ef016764974697970b

Listed below are links to weblogs that reference Solazyme and Bunge form joint venture for commercial-scale renewable oil production facility in Brazil:

Comments

That's about 570,000 bbl of oil. I guess the assumption is that the process will use waste from the sugar plant, it's never explicitly stated. It seems like a nice niche process, but it seems unlikely that we would do this in the US since we really like a one size fits all approach. Imagine any venture capitalist, banker, politician etc. in this country being interested in such a small project. Sure, a number of similar projects could collectively accumulate a significant benefit, but how would anyone make "publicly traded corporation kind of money" (you know you need to pay a lot of vice presidents), or how would a politician look if he or she said the answer was this thing that has limited applicability. No, there would be no support for that here, because money and power are what matter here in the US. I probably shouldn't have used the word collectively, it may make it seem like a socialist plot for rationality, and if you can get people to believe it is somehow socialist to be rational, we'll never get rational here, no we won't! So scratch "collectively" and replace it with "all together".

I am missing information on DME developments. What happened with black liquor to Bio DME project in Sweden?

For an amusing diversion, Google "Bunge JFK assassination"

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been posted. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Green Car Congress © 2014 BioAge Group, LLC. All Rights Reserved. | Home | BioAge Group